Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience.

Christian Müller,Jazan Omari,Konrad Mohnike, Caroline Bär,Maciej Pech,Verena Keitel,Marino Venerito

Cancers（2023）

引用 1|浏览0

暂无评分

摘要

Multidisciplinary discussion is critical for identifying patients with progressive uBTC who might benefit the most from MIT, FOLFIRI, or both. The safety profile was consistent with previous reports.

查看译文

关键词

cholangiocarcinoma,biliary tract cancer,second-line,FOLFIRI,multidisciplinary treatment,minimal invasive therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要